This is the second in a series of blogs on the virtual 2021 International IACFS/ME Conference, “A Huge Problem and Major Crisis”: Avindra Nath on Long COVID at the IACFS/ME 2021 Conference Dr. Scheibenbogen shows the impact that a leader in the field can have....
Every once in a blue moon you come across a study that kind of stops you in its tracks. This is that one for me. (Thanks to Tim Vaughn for pointing it out.) If the findings hold up it could transform our understanding and approach to fibromyalgia (FM). Plus, it has...
Paradigm Shift for Long COVID Patients (and people with ME/CFS)? The dramatic announcement that Congress is going to appropriate over a billion dollars (a billion dollars!) to study the COVID-19 long haulers was just one sign that long COVID is being taken seriously....
One of the great questions facing chronic fatigue syndrome (ME/CFS) is whether many COVID-19 long haulers will come down with an ME/CFS-like condition. Anecdotally, it appears likely that they will. A few, isolated studies are beginning to suggest the same. Recently,...
Autoimmune autonomic ganglionopathy is a very rare disease. So why feature it in a blog on chronic fatigue syndrome (ME/CFS), fibromyalgia (FM), and postural orthostatic tachycardia syndrome (POTS)? Because it could provide a preview of the future. All these diseases...
The findings are tentative and need to be validated, but if they hold up they could signal a fundamental split between people who’s chronic fatigue syndrome (ME/CFS) was triggered by an infection and those who came down with ME/CFS some other way. If your...
